Vertex Pharmaceuticals Incorpo

VRTX 
(NASDAQ) 
 
$ 157,63 <%= Resources.Global.txtUp %>
Opdateret 20-06-2018
Ændring % 2,03% Stigning i aktiekurs
Ændring 3,13 Stigning i aktiekurs
Volume 479.085
Høj $ 158,18
Lav $ 153,75
Åben $ 154,46
ISIN
Seneste luk $ 154,50
# af aktier 254,83M
Markedsværdi 40.169M USD
I dag

Market closed
Vertex Pharmaceuticals Incorpo
Markedet er lukket, åbner klokken 15:30
 
Kursudvikling Seneste 1 uge 1 måned 3 mdr 6 mdr 1 år
 
  157,63 1,7% Stigning i aktiekurs 0,9% Stigning i aktiekurs -7,5% Fald i aktiekurs 5,9% Stigning i aktiekurs 16,9% Stigning i aktiekurs
Powered by TradingView

Nyheder om Vertex Pharmaceuticals Incorpo

  • Dansk
  • Engelsk
  • Fondsbørsmeddelelser

Firmaprofil

Vertex Pharmaceuticals discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, and Symdeko for cystic fibrosis, in addition to several mid- and late-stage products targeting this market. Vertex successfully developed and commercialized two HIV protease inhibitors, which were outlicensed to GlaxoSmithKline. Vertex's pipeline also includes therapies for the treatment of cancer, pain, inflammatory diseases, influenza, and other rare diseases.

Copyright Euroinvestor A/S 2018  Disclaimer  |  Cookie- og privatlivspolitik  |  Persondatapolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
21. juni 2018 06:55:07
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20180619.1 - EUROWEB7 - 2018-06-21 06:55:07 - 2018-06-21 06:55:07 - 1 - Website: OKAY